Is therapy of people with chronic kidney disease ONTARGET?

Nephrol Dial Transplant. 2010 Jan;25(1):42-4. doi: 10.1093/ndt/gfp568. Epub 2009 Oct 23.

Authors

Johannes F E Mann¹, Sheldon Tobe, Koon K Teo, Salim Yusuf

Affiliation

¹ Population Health Research Institute, McMaster University, Hamilton, Canada. prof.j.mann@googlemail.com

PMID: 19854846
DOI: 10.1093/ndt/gfp568

No abstract available

MeSH terms

Angiotensin II Type 1 Receptor Blockers / adverse effects
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / adverse effects
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Benzimidazoles / adverse effects
Benzimidazoles / therapeutic use*
Benzoates / adverse effects
Benzoates / therapeutic use*
Blood Pressure / physiology
Chronic Disease
Dose-Response Relationship, Drug
Drug Therapy, Combination
Glomerular Filtration Rate / physiology
Humans
Kidney Diseases / drug therapy*
Kidney Diseases / physiopathology
Ramipril / adverse effects
Ramipril / therapeutic use*
Telmisartan
Treatment Outcome

Substances

Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Benzimidazoles
Benzoates
Ramipril
Telmisartan